Furthermore, it reiterates that the qMIDS assay robustly measures a universal oncogenic program driven by FOXM1, at least in HNSCC, which transcends ethnicity, age, gender and geographic origins. The gene discussed is FOXM1; the disease is head and neck squamous cell carcinoma.